Bioequivalence of oxymorphone extended release and crush-resistant oxymorphone extended release
Irma H Benedek, Janet Jobes, Qinfang Xiang, William D Fiske Endo Pharmaceuticals Inc, Chadds Ford, PA, USA Background: A formulation of crush-resistant extended-release opioids may deter abuse. The purpose of this study was to evaluate the bioequivalence of oxymorphone extended-release (Oxy-ER) and...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2011-10-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | http://www.dovepress.com/bioequivalence-of-oxymorphone-extended-release-and-crush-resistant-oxy-a8571 |